DNA — Ginkgo Bioworks Holdings Share News
0.000.00%
Last trade - 00:00- $653.87m
- $351.71m
- $170.16m
Brief: Prozomix, Ginkgo Bioworks Collaborate On Next-Gen Enzyme Development For Sustainable API Manufacturing
Brief: Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy Assets To Strengthen Next-Gen Car Designs
Brief: Ginkgo Bioworks Awarded Darpa Funding
Brief: Imagindairy And Ginkgo Bioworks Collaborate To Develop And Produce Animal-Free Non-Whey Dairy Proteins
U.S. STOCKS ON THE MOVE-Madrigal Pharma, Copper miners, NetApp
U.S. STOCKS ON THE MOVE-Cooper, US energy stocks, Vista Outdoor
U.S. STOCKS ON THE MOVE-Old Republic, TDCX, Repay Holdings
Ginkgo slumps after forecasting 2024 revenue below estimates
U.S. RESEARCH ROUNDUP-Broadcom, New York Community Bancorp, TopBuild
Ginkgo Bioworks Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Ginkgo Bioworks Q4 Net Income USD -211.694 Million
Brief: Ginkgo Bioworks Acquires Proof Diagnostics
Brief: Ginkgo Bioworks Acquires Patch Biosciences
Brief: Ginkgo Bioworks Acquires Reverie Labs Platform, Enhancing AI-Driven Drug Discovery Capabilities for Customer Programs
Ginkgo Bioworks Holdings Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Ginkgo Biosecurity Launches Doha-Based Pathogen Monitoring Center
U.S. STOCKS ON THE MOVE-Super Micro, Albemarle
U.S. STOCKS ON THE MOVE-Ginkgo, Jfrog, Alvotech
Ginkgo rises on $31 mln contract to develop vaccine adjuvants